Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind …
Background: Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
[引用][C] Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: A randomized, double …
M ESCHER, Y DAALI, J CHABERT… - Clinical …, 2007 - pascal-francis.inist.fr
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single
intravenous administration in healthy volunteers : A randomized, double-blind, placebo-controlled …
intravenous administration in healthy volunteers : A randomized, double-blind, placebo-controlled …
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: A randomized, double-blind …
M Escher, Y Daali, J Chabert… - … -Reviewed Journal of …, 2007 - psycnet.apa.org
Background: Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
[PDF][PDF] Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double …
Clinical Therapeutics, 2007 - Citeseer
Background: Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 rag, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 rag, and the usual parenteral dose is 0.3 mg for acute …
Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind …
M Escher, Y Daali, J Chabert, G Hopfgartner… - Clinical …, 2007 - infona.pl
Background: Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind …
M Escher, Y Daali, J Chabert, G Hopfgartner, P Dayer… - 2007 - pubmed.ncbi.nlm.nih.gov
Background Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind …
M Escher, Y Daali, J Chabert… - Clinical …, 2007 - clinicaltherapeutics.com
Background: Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind …
M Escher, Y Daali, J Chabert, G Hopfgartner… - Clinical …, 2007 - folia.unifr.ch
OBJECTIVE The aim of this study was to assess the pharmacokinetic properties of
buprenorphine 0.002 mg/kg IV (0.15 mg/70 kg) and its antinociceptive and psychomotor …
buprenorphine 0.002 mg/kg IV (0.15 mg/70 kg) and its antinociceptive and psychomotor …
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind …
M Escher, Y Daali, J Chabert, G Hopfgartner… - Clinical …, 2007 - sonar.ch
OBJECTIVE The aim of this study was to assess the pharmacokinetic properties of
buprenorphine 0.002 mg/kg IV (0.15 mg/70 kg) and its antinociceptive and psychomotor …
buprenorphine 0.002 mg/kg IV (0.15 mg/70 kg) and its antinociceptive and psychomotor …
Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind …
M Escher, Y Daali, J Chabert, G Hopfgartner… - Clinical …, 2007 - europepmc.org
Background Buprenorphine is used as an analgesic for postoperative and chronic pain. The
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …
usual sublingual dose is 0.2 to 0.8 mg, and the usual parenteral dose is 0.3 mg for acute …